Apollomics
Matthew Plunkett is an accomplished financial executive with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Chief Financial Officer at Apollomics since March 2024, Matthew has previously held similar roles at Aeovian Pharmaceuticals, Imago BioSciences, and Nkarta Therapeutics, where responsibilities included financial operations, strategic financing, and fostering relationships with investors. Notably, Matthew contributed to leading a $57 million Series B financing at Medeor Therapeutics while serving as Chief Financial & Business Officer. Educational credentials include a PhD in Chemistry and participation in The Berkeley Executive Leadership Program at the University of California, Berkeley.
This person is not in any teams
This person is not in any offices